Biotech Showcase 2019: VBC III Targets European Therapeutic, Medtech And Digital Health Opportunities

 
• By Mike Ward

Marc Lohrmann, managing partner of Versalius BioCapital's VBC III  fund, explains how the company is looking to invest in maturing European companies.

Video interview

More from Financing

More from Business